A brief report (KW Cheung et al. Clin Gastroenterol Hepatol 2018; 16: 144-5) describes a prospective multicenter study (2014-16) in Hong Kong which examined immunoprophylaxis failure (IF) of infants (n=654) born to mothers infected with hepatitis B virus (HBV) infection. All infants had received HBV vaccine and HBV immunoglobulin (within 12 hours of birth). Maternal HBV DNA & serology was measured at 28-30 weeks.
- There were 7 cases of IF (1.1%). All were born to women with positive HBeAg and HBV DNA >8 log10 copies/mL (>17 million IU/mL)
- The authors note that “although a cutoff of 200,000 IU/mL (~6 log10 copies/mL) has been recommend, the optimal viral load cutoff to initiate HBV antiviral treatment remains debatable.”
My take: HBV prophylaxis with HBV vaccination and HBIG is very effective. However, HBV DNA levels can be used to target HBV antiviral treatment to further minimize the chance of IF failure.
Related blog posts:
- Antivirals Reduce Vertical Transmission of Hepatitis B | gutsandgrowth
- Preventing Neonatal Hepatitis B Transmission with Tenofovir | gutsandgrowth
- Preventing Vertical Transmission of Hepatitis B with Telbivudine…
- How to stop HBV vertical transmission | gutsandgrowth